CTI Will File sNDA For Zevalin In Follicular Lymphoma, CEO Bianco Tells DAILY
This article was originally published in The Pink Sheet Daily
Executive Summary
Improvement in progression-free survival is seen in patients with advanced follicular lymphoma following treatment with Zevalin.